Rapid Message Testing with Consumer Panel - Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER)

Data to Support Drug Product Communications

OMB: 0910-0695

IC ID: 244796

Documents and Forms
Document Name
Document Type
Other-Interview Guide
Other-Screener
Other-DSC - Benadryl
Other-DSC - Immodium
Other-DSC - Nasadine
IC Document
Information Collection (IC) Details

View Information Collection (IC)

Rapid Message Testing with Consumer Panel - Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER) CDER
 
New
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Interview Guide Cognitive Interview Guide - Misuse and Abuse of OTCs.docx Yes Yes Printable Only
Other-Screener Screener - Misuse and Abuse of OTCs.docx Yes Yes Fillable Fileable
Other-DSC - Benadryl Drug Safety Communication for Benadryl.pdf Yes Yes Printable Only
Other-DSC - Immodium Drug Safety Communication for Imodium.pdf Yes Yes Printable Only
Other-DSC - Nasadine Drug Safety Communication for Nasadrine.pdf Yes Yes Printable Only

Health Consumer Health and Safety

 

1,500 0
   
Individuals or Households
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 1,500 0 1,500 0 0 0
Annual IC Time Burden (Hours) 89 0 89 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
OMB Approval Memo 0695 OMB Approval Memo - Misuse and Abuse of OTC Medications 2020.docx 12/08/2020
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.
© 2024 OMB.report | Privacy Policy